Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season

Influenza Vaccination in Patients With Chronic Heart Failure

“…5,12 Aside from country, the most significant predictors of vaccination included older age, history of diabetes mellitus, lower NYHA functional class, lower heart rate, use of digoxin, and use of either an ICD or CRT therapy. Influenza vaccination was associated with lower all-cause mortality even when adjusted for the propensity to receive influenza vaccine.…”

“…[1][2][3][4] Influenza vaccination is recommended annually for patients with cardiovascular disease by both the Centers for Disease Control and Prevention, the American Heart Association, and the European Center for Disease Prevention and Control. 5,6 A meta-analysis of randomized, controlled studies has shown that receiving influenza vaccination reduced the risk for major adverse cardiovascular events in patients with coronary artery disease compared to no vaccination. 7…”

The role of vaccination in successful independent ageing

“…Another strategy could be lifelong vaccination, with regular boosters, to keep antibodies above protective levels, as is generally recommended for tetanus and diphtheria. More recently, recommendations for seasonal influenza vaccination in the US have been extended to all individuals aged 6 months [35]. Extending the recommendations to younger individuals, and particularly to a lifelong vaccination recommendation, will, naturally, have economic repercussions.…”

Re-Inventing the Common Cold Institute for the 21st Century

“…Influenza and its associated diseases are a major cause of morbidity and mortality [20]. It is important to note that Influenza A (H3N2) causes the greatest morbidity and mortality on an annual basis [21] even when compared to the recent 2009 pandemic H1N1 strain [22]; hence it is an important focus for model development and antivirals, vaccines and novel diagnostics.…”